Work at the Pneumoconiosis Research Unit and elsewhere has shown that complicated pneumoconiosis is relatively common in the mining areas of Wales (Hart and Aslett, 1942; Cochrane, Davies, and Fletcher (1951) , that it is severely disabling in the later stages (Gilson and Hugh-Jones, in the press) and definitely reduces the expectation of life (Stewart, Davies, Dowsett, Morrell, and Pierce, 1948) . Neither change of occupation nor treatment has been shown to alter the course of the disease.
On the basis, however, of the considerable evidence that tuberculosis plays a major part in the aetiology of the progressive massive fibrosis (P.M.F.) of complicated pneumoconiosis (Fletcher and Gough, 1950; Van Mechelen, 1935) it seemed reasonable to see whether the rate of radiological progression could be influenced by chemotherapy which was known to be effective in the treatment of pulmonary tuberculosis.
A therapeutic trial of this kind presents unusual difficulties. To allow the maximum chance of success it was decided to include only the earlier cases of progressive massive fibrosis, occurring in relatively young men. However, men in this group have few serious symptoms and are in many cases earning high wages in the coal industry. It would therefore not have been justifiable to keep a large number of them in hospital for prolonged treatment unless very encouraging results of a pilot trial on in-patients had been available. On the other hand, a field experiment of streptomycin involving regular injections would have led inevitably to a high lapse rate. We finally decided therefore on a controlled trial using isoniazid. This avoided the administrative difficulties of injections and the toxic side-effects of streptomycin and P.A.S. which might have been serious in working men. As we were going to treat only cases in which the sputum was negative for tuberculosis, it seemed reasonable at the time the trial started, which was immediately isoniazid became available in this country, to proceed without waiting for further knowledge about the risks of drug resistance. The full extent of the problem was not then known.
The Design of the Trial The trial was designed to determine whether the administration of isoniazid to cases of early P.M.F. would diminish the radiological progression rate, which was known to be about 12-5% per annum for all cases, and greatest in early lesions in young men (Pneumoconiosis Research Unit, unpublished data). Accordingly men were selected who were thought likely to show, in the absence of treatment, the most rapid radiological progression; they were visited at their homes, volunteers were enlisted, and subsequently divided at random into two numerically equal groups, the treated and the controls.
Treatment
The dosage scheme used by the M.R.C. Tuberculosis Chemotherapy Trials Committee was followed (Medical Research Council, 1953) ; a dose of 100 mg. of isoniazid was given twice daily for three months to half the men; the remainder received indistinguishable inert tablets. The first three-month course was separated from a second similar course by an interval of four months. Assessment of the progress of the two groups was made five months after the end of this second course.
During each course tablets of 50 mg. each were distributed in bottles of 100, i.e. 25 days' supply, and every man or his wife was visited at least four times during each three-month course. The patient's physician was asked to continue treatment through intercurrent illnesses unless its discontinuation was thought essential.
Selection of Cases
The basic requirements for all cases before acceptance into the trial were: (1) That (Cochrane, Cox, and Jarman, 1952) , and, of the total of 6,026 films, 788 showed complicated pneumoconiosis; 296 of these were of men under the age of 50 with early massive shadows (Categories A and B. International Classification, Fletcher, 1950) . The films of these 296 were re-read and from them were excluded all cases with sharply defined shadows (an appearance thought to be associated with contraction and possibly indicative of a less active or burnt-out phase), all cases with cavitation, and all cases with the characteristic type of chest radiograph associated with rheumatoid arthritis in coal-workers (Caplan, 1953 (Middlebrook and Dubos, 1948; Scott and Smith, 1950) . (e) Each man was weighed. (f) Urine specimens were tested for protein.
Urine examinations were repeated after one month's treatment, at the end of the first course, and again at the beginning and end of the second course. All men were weighed at the end of the first course and before the second course, and plain posteroanterior chest radiographs were taken again at the start of the second course of treatment. After the preliminary investigations, eight of the 138 volunteers were excluded from the trial, three for absence of confluent opacity on tomography, three for albuminuria, one for mental deficiency, and one for carcinoma of the stomach. These exclusions left 130 men in the trial; they were divided at random into two numerically equal groups. gressing are not statistically significant. This Table  includes one control who developed positive sputum and was thereafter excluded from the trial; a chest radiograph taken after the completion of the first course of isoniazid had also shown progression. An attempt was made to determine in which interval the progression had taken place but this was found to be too difficult. Table 3 shows the interobserver error in the initial readings for progression. The extent of the error is somewhat larger than was expected from our experience, based on repeated surveys at collieries, but the interval between the two radiographs was in this case shorter. It is also probably true that the use of tomographs increased the differences between observers. Yerushalmy and others (1951) investigated the inter-observer error in reading progression and regression in cases of pulmonary tuberculosis and found that it was very much larger than their measurements of error in straightforward diagnosis had led them to expect.
Weight Changes.-Both groups increased in weight throughout the trial, the treated group by 2-7 Fourteen other men attributed symptoms to isoniazid tablets, including three who discontinued treatment. These symptoms were giddiness (6), disturbances of micturition (2), diarrhoea (2), drowsiness (2), headache (1), and nausea and epigastric pain (1). On the other hand seven of the controls attributed symptoms to the inert tablets as follows: giddiness (3), palpitations (2), haemoptysis (1), and epigastric pain (1).
Progression Related to Occupation.-Previous investigations by the Pneumoconiosis Research Unit had suggested that the progression of complicated pneumoconiosis was independent of dust exposure. Grouping " Progression" and "? Progression," x2 = 0-029 for 1 degree of freedom, 0-8 <P<0 9.
In Table 4 , the rate of progression of those exposed to dust is compared with those not so exposed; though the time interval is short, these findings appear to confirm the earlier work; the differences in the proportions progressing are not statistically significant.
Middlebrook-Dubos Agglutination Test.-Only four men in the trial gave a positive result at a titre of 1 in 8, a result which, by the method used, is said to be comparable with the findings in a control group of healthy non-tuberculous people (James, personal communication). None of these four showed any radiological progression during the trial, and three of the four had erythrocyte sedimentation rates of 10 mm. in one hour or less; furthermore the test was negative in the one case where the sputum became positive. It would seem therefore that a positive test is probably not indicative of a poor prognosis in complicated pneumoconiosis.
Erythrocyte Sedimentation Rate.- Martin (1948) found that the sedimentation rate had a definite prognostic value in complicated pneumoconiosis; the importance ofhis findings is somewhat diminished by the fact that 50% of his whole group died within two years, as this means his original group was very highly selected. Our findings in Table 5 confirm and extend the observations by Stewart and others (1948) that the E.S.R. has some prognostic value in P.M.F. in that the proportion showing definite or ? progression increases with increasing sedimentation rate, but analysis of the results grouped as in Table 6   TABLE 6 ANALYSIS OF DATA OF progress rates which are compatible into" treated " and" control" groups in a (probability greater than 5%) with results observed in trial. trial of the effects of isoniazid in this disease.
Isoniazid, 200 mg., was given daily to the treated in two three-monthly courses at home.
The results were assessed in the 101 men who completed both courses and in one man who had developed a positive sputum at the end of 16 months. Amongst the 102 men definite or suggestive radiological progression occurred in 21 % of the treated, 30% of the controls, but the difference is not statistically significant.
The trial showed no evidence that isoniazid has any dramatic effect in these cases, but the relative insensitivity of the trial did not exclude results compatible with some effect, the limits of which are discussed.
No serious complications or resistant tubercle bacilli were encountered.
A P P E N D I X Note on the Method Used to Derive Figure 1 If Pt and P2 are the true progression rates among the treated and control subjects respectively, the chance of obtaining 11 or more progressors among the 52 treated subjects studied is: Similarly, the chance of obtaining 11 or less progressors is Il_Pi (41, 12) . The corresponding probabilities in the control group are IP2 (15, 36) and I1-p2 (35, 16) .
The joint probability of the two independent samples or of more extreme ones can thus be written down at once in the form of products of two incomplete B-function ratios, and the limits of the values of Pt and P2 can be derived as those which make the product just less than 0-05. They can quickly be obtained by means of Pearson's tables (1934) .
